DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Søfteland E, Meier JJ, Vangen B. et al
Empagliflozin as add-on therapy in patients with type 2 diabetes inadequately controlled with linagliptin and metformin: a 24-week randomized, double-blind, parallel-group trial.
Diabetes Care 2017;
40: 201-209 . doi:10.2337/dc16-1347
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.